Judah Hannah R, Rigby Robert A, Stasinopoulos Mikis D, Pateras Konstantinos, Rahim Mussarat N, Heneghan Michael A, Nicolaides Kypros H, Kametas Nikos A
Fetal Medicine Research Institute, King's College Hospital, London SE5 8BB, United Kingdom.
School of Computing and Mathematical Sciences, University of Greenwich.
Am J Obstet Gynecol. 2025 Jul 1. doi: 10.1016/j.ajog.2025.06.056.
Liver dysfunction complicates 3% of pregnancies and prompt diagnosis reduces severe maternal and perinatal morbidity and mortality. Recognition of liver dysfunction relies on the creation of reference ranges. Outside pregnancy, factors such as age and gender have been shown to affect liver biomarkers but despite recommendations for age and gender-adjusted reference ranges for liver function tests, these have not been widely adopted clinically. In pregnancy, there are only a few studies that have examined changes of liver function tests (LFTs) with gestation, and none of them have controlled for maternal demographic characteristics.
The aims of this study are first, to provide reference ranges of LFTs in a large population of uncomplicated pregnancies after adjusting for the effect of gestational age and maternal demographic characteristics on the median and measures of dispersion and shape (skewness and kurtosis) of the distribution of these variables, and second, to create an on-line calculator of z-scores of maternal LFTs using the above-mentioned methodology.
This was a cross-sectional study of healthy women attending for routine antenatal ultrasound scans at 11 to 13 weeks' gestation (visit 1), 19 to 24 weeks (visit 2), 30 to 34 weeks (visit 3), and 35 to 37 weeks (visit 4). Women with a history of liver dysfunction or adverse pregnancy outcome were excluded from the analysis. We measured the following variables: alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma glutamyl transferase (GGT), total bilirubin (TBIL) and albumin (ALB). The assessment of the distribution of LFTs across gestational age, (controlling for maternal characteristics) was performed with Generalized Additive Models for Location, Scale, and Shape (GAMLSS), using the GAMLSS R package, which allows the implementation of distributions other than normal distribution.
There were 3451 women who agreed to participate in the study and had uncomplicated pregnancies. Women participated only once in the study with 805, 860, 886 and 900 women attending in visits 1, 2, 3 and 4, respectively. The location parameter of the distribution of the LFT variables is independently predicted by gestational age and ethnicity for all variables, by maternal body mass index (BMI) for all variables except ALB, by maternal age for all variables except ALT/AST ratio and GGT, by maternal parity for all variables except TBIL and ALP, by maternal smoking for TBIL and ALB, and by maternal weight for ALP. The scale parameter of the distribution is also independently predicted by gestational age for all variables apart from ALP, maternal BMI for ALT, AST, GGT and ALP, maternal age and ethnicity for GGT and maternal parity for ALT and AST. In contrast, the skewness and kurtosis of LFTs have a non-uniform influence by gestational age, and maternal ethnicity, BMI, age and parity. An on-line calculator of z-scores for the above-mentioned variables is given at https://fetalmedicinefoundation.shinyapps.io/life/ CONCLUSION: Assessing if a pregnant woman's LFTs deviate from the expected normal values, necessitates adjusting for gestational age and maternal demographic characteristics both for the median and measures of dispersion and shape of the distribution.
肝功能障碍在3%的妊娠中出现并发症,及时诊断可降低严重的孕产妇和围产期发病率及死亡率。肝功能障碍的识别依赖于参考范围的建立。在非孕期,年龄和性别等因素已被证明会影响肝脏生物标志物,但尽管有建议采用年龄和性别调整后的肝功能测试参考范围,但这些在临床上尚未被广泛采用。在孕期,只有少数研究探讨了肝功能测试(LFTs)随孕周的变化,且均未对孕产妇人口统计学特征进行控制。
本研究的目的一是在调整孕周和孕产妇人口统计学特征对这些变量分布的中位数、离散度和形状(偏度和峰度)的影响后,提供大量无并发症妊娠人群的LFTs参考范围;二是使用上述方法创建一个孕产妇LFTs z分数的在线计算器。
这是一项对在妊娠11至13周(第1次就诊)、19至24周(第2次就诊)、30至34周(第3次就诊)和35至37周(第4次就诊)进行常规产前超声扫描的健康女性的横断面研究。有肝功能障碍病史或不良妊娠结局的女性被排除在分析之外。我们测量了以下变量:碱性磷酸酶(ALP)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、γ-谷氨酰转移酶(GGT)、总胆红素(TBIL)和白蛋白(ALB)。使用广义位置、尺度和形状加性模型(GAMLSS)以及GAMLSS R包,对孕周(控制孕产妇特征)进行LFTs分布评估,该模型允许实现非正态分布。
有3451名同意参与研究且妊娠无并发症的女性。女性仅参与研究一次,分别有805、860、886和900名女性参加第1、2、3和4次就诊。LFT变量分布的位置参数由孕周和种族独立预测所有变量,由孕产妇体重指数(BMI)预测除ALB外的所有变量,由孕产妇年龄预测除ALT/AST比值和GGT外的所有变量,由孕产妇产次预测除TBIL和ALP外的所有变量,由孕产妇吸烟情况预测TBIL和ALB,由孕产妇体重预测ALP。除ALP外,所有变量分布的尺度参数也由孕周独立预测,ALT、AST、GGT和ALP由孕产妇BMI预测,GGT由孕产妇年龄和种族预测,ALT和AST由孕产妇产次预测。相比之下,LFTs的偏度和峰度受孕周、孕产妇种族、BMI、年龄和产次的影响不一致。上述变量的z分数在线计算器可在https://fetalmedicinefoundation.shinyapps.io/life/获取。结论:评估孕妇的LFTs是否偏离预期正常值,需要对孕周和孕产妇人口统计学特征进行调整,包括分布的中位数、离散度和形状。